← Leaderboards
Adela Rambi Cardones
Duke University
$689,460
Attributed
$1,876,165
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $945.6K · FY2019–20$1M$750K$500K$250K$0
'19
'20
Funding mix
By agency
NIH$1,876,165 · 2
By mechanism
R42$1,491,733 · 1
R21$384,432 · 1
Top collaborators
- Peter Hollender2 shared
- Mark L. Palmeri2 shared
- Yunyan Jennifer Jennifer Zhang2 shared
Most similar at Duke University
Same institution · by research overlap
- Terry H Lechler$14,490,046
- Andrew Serghios Barbas$3,383,335
- Jeffrey R. Marks$14,495,323
- Jean Kwun$6,486,375
- Aravind Asokan$26,081,479
Others in their field
Other Emerging Leaders on “Skin Disorder”
- Huiqing You · Kai Research, Inc$8,078,483
- Gabriel Nestor Sanchez · Enspectra Health, Inc.$7,941,485
- Todd Levine · Cnd Life Sciences, Inc.$7,820,585
- Sviatoslav Bagriantsev · Yale University$5,754,442
- Allison L Kraus · Case Western Reserve University$5,232,285
- Rachelle L Crescenzi · Vanderbilt University Medical Center$4,889,806
Research focus
Skin DisorderSclerosisMorbidity - Disease RateSkinTransplant RecipientsBiological MarkersDoseLifeMortalitySeverity Of IllnessTissuesTranscriptome SequencingBiopsyAllogenicDermalDisease ProgressionGraft Vs Host DiseaseHematopoietic Stem Cell TransplantationChronic Graft Versus Host DiseaseBaseOutcome PredictionBone MarrowBiomarker ValidationClinical Imaging
Grant awards (4)
Ultrasound-Based Device to Guide Treatment of Graft-Versus-Host-Disease using Skin Elasticity as a Biomarker$770,507
R42 · FY2020 · CA
Keratinocyte targeted strategies for treatment of cutaneous GVHD$175,088
R21 · FY2020 · CA
Ultrasound-Based Device to Guide Treatment of Graft-Versus-Host-Disease using Skin Elasticity as a Biomarker$721,226
R42 · FY2019 · CA
Keratinocyte targeted strategies for treatment of cutaneous GVHD$209,344
R21 · FY2019 · CA